000 | 01641 a2200493 4500 | ||
---|---|---|---|
005 | 20250514193634.0 | ||
264 | 0 | _c20040824 | |
008 | 200408s 0 0 ger d | ||
022 | _a0340-2592 | ||
024 | 7 |
_a10.1007/s00120-004-0575-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLaufs, U | |
245 | 0 | 0 |
_a["Anti-aging" from a cardiologist's view]. _h[electronic resource] |
260 |
_bDer Urologe. Ausg. A _cMay 2004 |
||
300 |
_a587-95; quiz 596 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAging _xdrug effects |
650 | 0 | 4 |
_aAlcohol Drinking _xepidemiology |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
650 | 0 | 4 |
_aCardiotonic Agents _xtherapeutic use |
650 | 0 | 4 |
_aCardiovascular Diseases _xmortality |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aDiet Therapy _xmethods |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aEvidence-Based Medicine |
650 | 0 | 4 |
_aExercise Therapy _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 |
_aHormones _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 |
_aRisk Assessment _xmethods |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSmoking _xepidemiology |
650 | 0 | 4 |
_aVitamins _xtherapeutic use |
700 | 1 | _aBöhm, M | |
773 | 0 |
_tDer Urologe. Ausg. A _gvol. 43 _gno. 5 _gp. 587-95; quiz 596 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00120-004-0575-9 _zAvailable from publisher's website |
999 |
_c14953116 _d14953116 |